Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

June 18, 2007

Roche's market share will go up .

Analysis of: New Data Confirms Significant Improvement of Disease Signs and Symptoms in Patients with Rheumatoid Arthritis | pharmalive.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Dipti Doshi, MD
Rheumatologist, HEALTHCARE PARTNERS MEDICAL GROUP
Implications: Very important new treatment emerging in field of rheumatoid arthritis along with other drugs in pipeline. IL-6 receptor blocker. New Mechanism of action. Has positive priliminary endpoint results at 24 week study for RA compared to DMARD therapy alone.

Analysis: comparable to products like rituximab can impact on.

Other Analyses of the Same Source Article:
Actemra - my kingdom for some data
June 14, 2007, Author: GLG Expert Contributor
help for the biologics failures? with RA
June 13, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-10-12T21:45:17.397